This site is intended for Healthcare Professionals only.

STADA appoints Wolfgang Ollig as Group CFO

Date:

Share post:

STADA, parent company of Yorkshire based pharmaceutical company Thornton & Ross, named Wolfgang Ollig as its new Group Chief Financial Officer.

Ollig replaces Mark Keatley who decided to step down for personal reasons. He will take up the new role on February 1.

Ollig has more than 15 years of experience in the role at various industries including medical and automotive. He has recently worked for hearing aid manufacturers WSA, A.S. Denmark, based in Singapore. Prior to this, he served Hella KGaA Hueck & Co ten years as Group CFO.

He also worked several years at McKinsey.

“Wolfgang’s deep knowledge in managing all financial aspects of a global company with broad portfolios, as well as his passion and strong credibility, will help to accelerate STADA’s ongoing growth journey,” said Peter Goldschmidt, STADA Chief Executive.

Ollig is expected to play a crucial part in realising the company’s vision of becoming the partner of choice in generics as well as in consumer health and to outperform the industry in terms of growth and profitability.

“I am really looking forward to joining the team and contributing to making STADA the leading company in the industry,” he said.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

UK launches new 5-year national plan to combat antimicrobial resistance

The plan outlines ambitious targets to drive down inappropriate use of antimicrobials and stimulate further development of new...

Pharmacy bodies unite to enhance workforce wellbeing

The RPS/PS workforce wellbeing survey 2023 revealed that most pharmacists continue to operate under challenging conditions, with elevated...

Northern Ireland releases plan to fully realise the potential of community pharmacies

NI Community Pharmacy Strategic Plan 2030 envisions an expansion of clinical services offered by community pharmacies The Department...

Britain refuses to sign WHO pandemic accord over vaccine sharing

As per the pandemic accord, 20 % of tests, treatments and vaccines to be shared among poorer countries  Britain...